Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Amlexanox | hsa00030 | Pentose phosphate pathway | 4.66E-02 | 3 | P60891, P04075, P37837 | PRPS1, ALDOA, TALDO1 | More | | Amlexanox | hsa00071 | Fatty acid degradation | 1.72E-02 | 4 | P11310, O75521, P11766, P33121 | ACADM, ECI2, ADH5, ACSL1 | More | | Amlexanox | hsa00220 | Arginine biosynthesis | 4.33E-02 | 2 | P05089, P49448 | ARG1, GLUD2 | More | | Amlexanox | hsa00500 | Starch and sucrose metabolism | 2.84E-03 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Amlexanox | hsa00512 | Mucin type O-glycan biosynthesis | 2.11E-02 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | | Amlexanox | hsa00514 | Other types of O-glycan biosynthesis | 3.37E-02 | 2 | P15907, Q8N4A0 | ST6GAL1, GALNT4 | More | | Amlexanox | hsa00564 | Glycerophospholipid metabolism | 3.93E-02 | 3 | P49619, O14494, Q3LIE5 | DGKG, PLPP1, ADPRM | More | | Amlexanox | hsa00760 | Nicotinate and nicotinamide metabolism | 2.11E-02 | 2 | P43490, Q13423 | PBEF1, NNT | More | | Amlexanox | hsa00910 | Nitrogen metabolism | 4.33E-02 | 2 | P22748, P49448 | CA4, GLUD2 | More | | Amlexanox | hsa00970 | Aminoacyl-tRNA biosynthesis | 2.11E-02 | 2 | O95363, P54136 | FARS2, RARS1 | More | | Amlexanox | hsa01200 | Carbon metabolism | 4.29E-02 | 4 | P04406, O14521, Q9P2R7, Q02252 | GAPDH, SDHD, SUCLA2, ALDH6A1 | More | | Amlexanox | hsa03010 | Ribosome | 5.87E-03 | 12 | P62753, P39019, P42677, P62906, P62917, Q07020, P61513, Q02878, P63173, P36578, P05386, P23396 | RPS6, RPS19, RPS27, RPL10A, RPL8, RPL18, RPL37A, RPL6, RPL38, RPL4, RPLP1, RPS3 | More | | Amlexanox | hsa03013 | RNA transport | 5.07E-04 | 14 | O14980, P52298, Q09161, O14893, P61326, Q7Z3B4, P35658, P47813, Q14152, O75822, Q14240, Q9Y6A5, Q06787, P51114 | XPO1, NCBP2, NCBP1, GEMIN2, MAGOH, NUP54, NUP214, EIF1AX, EIF3A, EIF3J, EIF4A2, TACC3, FMR1, FXR1 | More | | Amlexanox | hsa03040 | Spliceosome | 3.11E-02 | 7 | O14776, O75940, P09651, O75494, Q07955, O95777, O43395 | TCERG1, SMNDC1, HNRNPA1, FUSIP1, SFRS1, LSM8, PRPF3 | More | | Amlexanox | hsa03060 | Protein export | 2.43E-02 | 2 | Q15070, O76094 | OXA1L, SRP72 | More | | Amlexanox | hsa04060 | Cytokine-cytokine receptor interaction | 4.07E-03 | 14 | P32927, P27930, P01584, P61073, P25024, P25025, Q9UBD3, P47992, P20333, P01375, P09341, Q99731, P18510, Q93038 | CSF2RB, IL1R2, IL1B, CXCR4, CXCR1, CXCR2, XCL2, XCL1, TNFRSF1B, TNF, CXCL1, CCL19, IL1RN, TNFRSF25 | More | | Amlexanox | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 5.73E-04 | 10 | Q99731, P09341, P25024, P25025, P61073, P47992, Q9UBD3, P09603, P20333, P01375 | CCL19, CXCL1, CXCR1, CXCR2, CXCR4, XCL1, XCL2, CSF1, TNFRSF1B, TNF | More | | Amlexanox | hsa04062 | Chemokine signaling pathway | 1.88E-03 | 10 | P25024, P25025, P09341, P47992, Q9UBD3, P07948, P63218, P50151, Q08881, P49841 | CXCR1, CXCR2, CXCL1, XCL1, XCL2, LYN, GNG5, GNG10, ITK, GSK3B | More | | Amlexanox | hsa04064 | NF-kappa B signaling pathway | 1.52E-02 | 10 | O00463, P01584, P01375, Q04759, Q16548, P06239, P63279, P24522, P09341, Q99731 | TRAF5, IL1B, TNF, PRKCQ, BCL2A1, LCK, UBE2I, GADD45A, CXCL1, CCL19 | More | | Amlexanox | hsa04071 | Sphingolipid signaling pathway | 4.43E-02 | 6 | P01375, Q13362, Q16537, Q9BX95, Q16539, P10415 | TNF, PPP2R5C, PPP2R5E, SGPP1, MAPK14, BCL2 | More | | Amlexanox | hsa04080 | Neuroactive ligand-receptor interaction | 1.61E-02 | 5 | P43657, Q01726, P21730, P14416, P35318 | P2RY5, MC1R, C5AR1, DRD2, ADM | More | | Amlexanox | hsa04114 | Oocyte meiosis | 2.67E-02 | 7 | Q9UJX2, Q14643, P22694, Q16539, Q14683, Q13362, Q16537 | CDC23, ITPR1, PRKACB, MAPK14, SMC1A, PPP2R5C, PPP2R5E | More | | Amlexanox | hsa04145 | Phagosome | 3.11E-02 | 2 | P01889, P10321 | HLA-B, HLA-C | More | | Amlexanox | hsa04218 | Cellular senescence | 1.60E-02 | 2 | P01889, P10321 | HLA-B, HLA-C | More | | Amlexanox | hsa04330 | Notch signaling pathway | 2.93E-02 | 3 | Q13547, Q92769, Q92830 | HDAC1, HDAC2, KAT2A | More | | Amlexanox | hsa04390 | Hippo signaling pathway | 1.52E-02 | 4 | P63261, Q13485, O15105, O43623 | ACTG1, SMAD4, SMAD7, SNAI2 | More | | Amlexanox | hsa04514 | Cell adhesion molecules | 2.20E-02 | 2 | P01889, P10321 | HLA-B, HLA-C | More | | Amlexanox | hsa04520 | Adherens junction | 3.44E-02 | 3 | Q13485, O43623, P63261 | SMAD4, SNAI2, ACTG1 | More | | Amlexanox | hsa04612 | Antigen processing and presentation | 2.01E-05 | 4 | P04233, P01889, P10321, Q06323 | CD74, HLA-B, HLA-C, PSME1 | More | | Amlexanox | hsa04621 | NOD-like receptor signaling pathway | 3.24E-02 | 9 | Q16539, Q14643, P21796, P10599, P43490, O00463, P29728, P09341, P12838 | MAPK14, ITPR1, VDAC1, TXN, PBEF1, TRAF5, OAS2, CXCL1, DEFA4 | More | | Amlexanox | hsa04640 | Hematopoietic cell lineage | 6.83E-03 | 9 | P13612, P14778, P27930, P15144, P11836, P07766, P09693, P01732, P09603 | ITGA4, IL1R1, IL1R2, ANPEP, MS4A1, CD3E, CD3G, CD8A, CSF1 | More | | Amlexanox | hsa04650 | Natural killer cell mediated cytotoxicity | 1.85E-05 | 13 | P01375, P78314, P06239, O60880, P20963, Q29983, P10321, P01889, Q13241, P26718, O75015, P26717, P26715 | TNF, SH3BP2, LCK, SH2D1A, CD247, MICA, HLA-C, HLA-B, KLRD1, KLRK1, FCGR3B, KLRC2, KLRC1 | More | | Amlexanox | hsa04658 | Th1 and Th2 cell differentiation | 1.59E-04 | 12 | Q04759, P07766, P20963, P09693, Q16539, P06239, Q14765, P23771, Q9UL17, P46531, Q9UM47, Q13761 | PRKCQ, CD3E, CD247, CD3G, MAPK14, LCK, STAT4, GATA3, TBX21, NOTCH1, NOTCH3, RUNX3 | More | | Amlexanox | hsa04659 | Th17 cell differentiation | 3.32E-02 | 7 | Q04759, Q16539, P14778, Q9UL17, P07766, P09693, P20963 | PRKCQ, MAPK14, IL1R1, TBX21, CD3E, CD3G, CD247 | More | | Amlexanox | hsa04660 | T cell receptor signaling pathway | 1.05E-04 | 13 | P01375, Q04759, O95267, Q08881, Q9NQU5, P07766, P20963, P09693, P01732, Q13191, P06239, Q16539, P49841 | TNF, PRKCQ, RASGRP1, ITK, PAK6, CD3E, CD247, CD3G, CD8A, CBLB, LCK, MAPK14, GSK3B | More | | Amlexanox | hsa04662 | B cell receptor signaling pathway | 2.61E-02 | 4 | P49841, P60033, P07948, Q8N149 | GSK3B, CD81, LYN, LILRA2 | More | | Amlexanox | hsa04664 | Fc epsilon RI signaling pathway | 4.19E-02 | 3 | Q16539, P07948, P09917 | MAPK14, LYN, ALOX5 | More | | Amlexanox | hsa04668 | TNF signaling pathway | 2.69E-02 | 8 | P01375, O00463, P18848, P09341, P01584, P20749, P14780, P20333 | TNF, TRAF5, ATF4, CXCL1, IL1B, BCL3, MMP9, TNFRSF1B | More | | Amlexanox | hsa04724 | Glutamatergic synapse | 1.11E-02 | 4 | P43003, P63218, P50151, P15104 | SLC1A3, GNG5, GNG10, GLUL | More | | Amlexanox | hsa04728 | Dopaminergic synapse | 2.96E-02 | 5 | P14416, P63218, P50151, P49841, Q16539 | DRD2, GNG5, GNG10, GSK3B, MAPK14 | More | | Amlexanox | hsa04940 | Type I diabetes mellitus | 4.45E-03 | 2 | P01889, P10321 | HLA-B, HLA-C | More | | Amlexanox | hsa04964 | Proximal tubule bicarbonate reclamation | 4.33E-02 | 2 | P22748, P49448 | CA4, GLUD2 | More | | Amlexanox | hsa05014 | Amyotrophic lateral sclerosis | 3.44E-02 | 13 | P01375, P10415, Q16539, Q16718, O14521, Q9NZJ5, Q13561, P09651, Q7Z3B4, P35658, P43243, Q09161, Q16629 | TNF, BCL2, MAPK14, NDUFA5, SDHD, EIF2AK3, DCTN2, HNRNPA1, NUP54, NUP214, MATR3, NCBP1, SFRS7 | More | | Amlexanox | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.85E-04 | 5 | Q16539, P09341, P25024, P25025, P07948 | MAPK14, CXCL1, CXCR1, CXCR2, LYN | More | | Amlexanox | hsa05143 | African trypanosomiasis | 3.23E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Amlexanox | hsa05144 | Malaria | 2.29E-02 | 5 | P60033, P01375, P35443, P01584, P26718 | CD81, TNF, THBS4, IL1B, KLRK1 | More | | Amlexanox | hsa05146 | Amoebiasis | 2.69E-02 | 8 | P01584, P09341, P27930, P01375, P05089, P22694, P12814, P08311 | IL1B, CXCL1, IL1R2, TNF, ARG1, PRKACB, ACTN1, CTSG | More | | Amlexanox | hsa05163 | Human cytomegalovirus infection | 1.18E-03 | 10 | P63218, P50151, Q14643, Q14344, P49841, P14778, P25025, Q16539, O00463, P30101 | GNG5, GNG10, ITPR1, GNA13, GSK3B, IL1R1, CXCR2, MAPK14, TRAF5, PDIA3 | More | | Amlexanox | hsa05165 | Human papillomavirus infection | 5.90E-03 | 3 | P01889, P10321, O14745 | HLA-B, HLA-C, SLC9A3R1 | More | | Amlexanox | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 2.25E-03 | 11 | P01889, P10321, P49841, P63218, P50151, P09341, Q14643, O15123, P07948, Q29983, Q16539 | HLA-B, HLA-C, GSK3B, GNG5, GNG10, CXCL1, ITPR1, ANGPT2, LYN, MICA, MAPK14 | More | | Amlexanox | hsa05168 | Herpes simplex virus 1 infection | 6.41E-03 | 3 | P04233, P01889, P10321 | CD74, HLA-B, HLA-C | More | | Amlexanox | hsa05169 | Epstein-Barr virus infection | 1.03E-04 | 15 | Q13547, Q92769, O00463, Q16539, P07948, P01889, P10321, P30101, Q13761, P24522, P30279, P29728, P07766, P09693, P20963 | HDAC1, HDAC2, TRAF5, MAPK14, LYN, HLA-B, HLA-C, PDIA3, RUNX3, GADD45A, CCND2, OAS2, CD3E, CD3G, CD247 | More | | Amlexanox | hsa05170 | Human immunodeficiency virus 1 infection | 2.87E-02 | 2 | P01889, P10321 | HLA-B, HLA-C | More | | Amlexanox | hsa05171 | Coronavirus disease - COVID-19 | 2.56E-02 | 15 | P01375, P01584, P23396, P62753, P39019, P42677, P62906, P36578, Q02878, P62917, Q07020, P61513, P63173, P05386, P21730 | TNF, IL1B, RPS3, RPS6, RPS19, RPS27, RPL10A, RPL4, RPL6, RPL8, RPL18, RPL37A, RPL38, RPLP1, C5AR1 | More | | Amlexanox | hsa05202 | Transcriptional misregulation in cancer | 4.88E-02 | 8 | P01106, P35226, O60583, P04141, P59665, P59666, P42773, O75293 | MYC, BMI1, CCNT2, CSF2, DEFA1; DEFA1B, DEFA3, CDKN2C, GADD45B | More | | Amlexanox | hsa05203 | Viral carcinogenesis | 1.99E-02 | 2 | P01889, P10321 | HLA-B, HLA-C | More | | Amlexanox | hsa05206 | MicroRNAs in cancer | 3.11E-02 | 6 | P01106, P26358, Q9UM47, P35226, Q96EB6, P19174 | MYC, DNMT1, NOTCH3, BMI1, SIRT1, PLCG1 | More | | Amlexanox | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 3.65E-02 | 6 | O95267, P07766, P20963, P09693, Q04759, Q16539 | RASGRP1, CD3E, CD247, CD3G, PRKCQ, MAPK14 | More | | Amlexanox | hsa05320 | Autoimmune thyroid disease | 3.49E-03 | 2 | P01889, P10321 | HLA-B, HLA-C | More | | Amlexanox | hsa05321 | Inflammatory bowel disease | 3.10E-02 | 5 | P01375, Q14765, Q9UL17, P23771, P01584 | TNF, STAT4, TBX21, GATA3, IL1B | More | | Amlexanox | hsa05330 | Allograft rejection | 3.49E-03 | 2 | P01889, P10321 | HLA-B, HLA-C | More | | Amlexanox | hsa05332 | Graft-versus-host disease | 4.45E-03 | 2 | P01889, P10321 | HLA-B, HLA-C | More | | Amlexanox | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.29E-02 | 4 | P23229, P16144, P60709, P35609 | ITGA6, ITGB4, ACTB, ACTN2 | More | | Amlexanox | hsa05416 | Viral myocarditis | 5.53E-03 | 2 | P01889, P10321 | HLA-B, HLA-C | More | | |